fulvestrant has been researched along with nafoxidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collins, DC; Gagliardi, A | 1 |
| Logie, C; Nichols, M; Rientjes, JM; Stewart, AF | 1 |
| Chakraborty, P; Droogmans, G; Maertens, C; Nilius, B | 1 |
3 other study(ies) available for fulvestrant and nafoxidine
| Article | Year |
|---|---|
Inhibition of angiogenesis by antiestrogens.
Topics: Animals; Chick Embryo; Clomiphene; Dimethyl Sulfoxide; Dimethylformamide; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Estrogen Antagonists; Fulvestrant; Heparin; Hydrocortisone; Nafoxidine; Neovascularization, Pathologic; Polyunsaturated Alkamides; Solubility; Tamoxifen | 1993 |
FLP recombinase/estrogen receptor fusion proteins require the receptor D domain for responsiveness to antagonists, but not agonists.
Topics: Amino Acid Sequence; Bacterial Outer Membrane Proteins; Diethylstilbestrol; DNA Nucleotidyltransferases; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Fulvestrant; Hexestrol; HSP90 Heat-Shock Proteins; Humans; Ligands; Molecular Sequence Data; Nafoxidine; Piperidines; Raloxifene Hydrochloride; Receptors, Estrogen; Recombinant Fusion Proteins; Tamoxifen; Time Factors; Yeasts | 1997 |
Inhibition of volume-regulated anion channels in cultured endothelial cells by the anti-oestrogens clomiphene and nafoxidine.
Topics: Cell Division; Cells, Cultured; Chloride Channels; Clomiphene; Enclomiphene; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Fulvestrant; Humans; Membrane Potentials; Nafoxidine; Patch-Clamp Techniques; Pulmonary Artery | 2001 |